Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Knutsen

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal of Clinical Immunology|July 30, 2017
Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label StudyMichael Borte, Isaac R Melamed, Grazyna Pulka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2003
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus ConferenceDavid A Stevens, Richard B Moss, Viswanath P Kurup, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2012
Fungi and allergic lower respiratory tract diseasesAlan P Knutsen, Robert K Bush, Jeffrey G Demain, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2025
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or OlderAaron T Chin, Hans D Ochs, Roger Kobayashi, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2022
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 DefinitionsChristopher C Dvorak, Elie Haddad, Jennifer Heimall, et al.
Blood Advances|November 25, 2025
Outcomes Following Matched Sibling Donor Transplantation for Severe Combined Immunodeficiency: A Report from the PIDTCAhmad Rayes, Brent R Logan, Xuerong Liu, et al.
Journal of Clinical Immunology|October 2, 2020
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC CentersMorna J Dorsey, Nicola A M Wright, Natalia S Chaimowitz, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2016
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantationM Teresa de la Morena, David Leonard, Troy R Torgerson, et al.
Journal of Clinical Immunology|December 4, 2020
Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC CentersMorna Dorsey, Nicola A M Wright, Natalia S Chaimowitz, et al.
Lancet (London, England)|June 23, 2023
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment ConsortiumMonica S Thakar, Brent R Logan, Jennifer M Puck, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Clinical Immunology|July 30, 2017
Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label StudyMichael Borte, Isaac R Melamed, Grazyna Pulka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2003
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus ConferenceDavid A Stevens, Richard B Moss, Viswanath P Kurup, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2012
Fungi and allergic lower respiratory tract diseasesAlan P Knutsen, Robert K Bush, Jeffrey G Demain, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2025
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or OlderAaron T Chin, Hans D Ochs, Roger Kobayashi, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2022
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 DefinitionsChristopher C Dvorak, Elie Haddad, Jennifer Heimall, et al.
Blood Advances|November 25, 2025
Outcomes Following Matched Sibling Donor Transplantation for Severe Combined Immunodeficiency: A Report from the PIDTCAhmad Rayes, Brent R Logan, Xuerong Liu, et al.
Journal of Clinical Immunology|October 2, 2020
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC CentersMorna J Dorsey, Nicola A M Wright, Natalia S Chaimowitz, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2016
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantationM Teresa de la Morena, David Leonard, Troy R Torgerson, et al.
Journal of Clinical Immunology|December 4, 2020
Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC CentersMorna Dorsey, Nicola A M Wright, Natalia S Chaimowitz, et al.
Lancet (London, England)|June 23, 2023
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment ConsortiumMonica S Thakar, Brent R Logan, Jennifer M Puck, et al.
Pageof 6